:Role of cytophilic anti-tumor antibodies in indirect MAI response of patients with HCC
スポンサーリンク
概要
- 論文の詳細を見る
The reactive cell in micro-leukocyte adherence inhibition (micro-LAI) assay was investigated in patients with HCC, using extract of human HCC cell line, "HCC-M" as specific antigen. Monocytes exhibited obvious reactivity among mononuclear cells. Separated monocytes from peripheral blood of patients with HCC also showed reactivity in the micro-LAI assay. For the purpose of analyzing effect of serum factor on the monocyte adherence inhibition, Indirect MAI assay Was perfomed. After healthy donor's monocytes were incubated with sera from patients With HCC, the micro-LAI assay was done. As a result, 11 out of 21 sera from patients with HCC showed positive reactivity in Indirect MAI assay, This "arming" factor of serum was involved in IgG fraction. Furthermore Antibody-Dependent Monocyte-Mediated Cytotoxicity (ADMC) assay was studied by measuring the lysis of HCC, M by healthy donor's monocytes preincubated with sera from patients with HCC. Sera from patients with HCC who had a positive Indirect MAI response increased the cytotoxicity of monocytes to HCC-M as compared with those from healthy controls. These results suggested that in some patients with HCC, there were circulating cytiphilic anti-tumor antibodies which participated in MAI response and ADMC to HCC.
- 社団法人 日本肝臓学会の論文
著者
関連論文
- Tube LAI assayによる肝細胞癌の診断―“repeated LAI assay”の意義と応用―
- ヒト肝細胞に特異的なマウスモノクローナル抗体H2およびB2
- 免疫賦活剤投与によるヌードマウスNK活性増強とヒト肝癌細胞株移植に対する抵抗性
- 継代培養人肝癌細胞を標的細胞とした肝細胞癌患者におけるCytotoxicity Assay : 第5報 肝癌細胞との混合培養によるCytotoxic T lymphocyteの誘導
- :Role of cytophilic anti-tumor antibodies in indirect MAI response of patients with HCC